A flexible implantable battery for medical use and its preparation method, and a leadless cardiac pacemaker.
By using a flexible thin-film positive electrode and a multi-point distributed fixation structure, the rigidity limitations and fixation limitations of leadless cardiac pacemakers have been overcome, achieving high energy density, long lifespan, and biocompatibility, making it suitable for minimally invasive implantation in pediatric patients.
Patent Information
- Application Number
- CN202611375215.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-09-07
- Publication Date
- 2026-11-10
AI Technical Summary
Existing leadless pacemakers suffer from limitations in structural rigidity and size, fixation methods, and battery form factors, making them particularly difficult to use in pediatric patients. Furthermore, traditional methods for manufacturing flexible batteries suffer from issues such as active material shedding and poor conductivity.
A self-supporting flexible thin-film cathode is used, and a three-dimensional network skeleton is constructed by shearing and fibrous polytetrafluoroethylene binder. Combined with a solid or quasi-solid polymer electrolyte and a biocompatible encapsulation layer, multiple flexible battery long arms are designed to be connected in parallel with the central base column to form an inverted umbrella-shaped or spherical cage-shaped fixed structure.
It achieves high energy density, long lifespan, flexibility and biocompatibility, adapts to complex implantation environments, reduces the risk of damage to myocardial tissue, and is suitable for minimally invasive implantation and pediatric patients.
Smart Images

Figure CN123059282A_ABST
Abstract
Description
Technical Field
[0001] This invention belongs to the field of medical implantable device technology, specifically relating to a medical implantable flexible battery and its preparation method, and a leadless cardiac pacemaker. Background Technology
[0002] In recent years, leadless pacemaker technology has emerged and has been successfully applied in clinical practice. Existing leadless pacing systems include representative products such as Medtronic's Micra Transcatheter Pacing System (TPS) and Abbott's Aveir leadless pacemaker. These devices integrate a battery, circuitry, and electrodes into a tiny capsule-shaped device, which is implanted directly into the ventricle via a catheter, thus eliminating complications associated with electrode leads and pockets.
[0003] However, existing leadless pacemaker technology still faces the following challenges:
[0004] Firstly, there are limitations in structural rigidity and size. Existing devices have rigid, cylindrical batteries and casings, and this fixed shape and volume restricts further miniaturization. For example, the Micra TPS measures approximately 25.9 mm in length and 6.7 mm in width, with a volume of 0.8 cm³; the Aveir LP measures approximately 38 mm in length and 6.5 mm in width, with a volume of 1.1 cm³. For specific patient groups, especially children, whose heart chambers are smaller and blood vessels are finer, implanting rigid cylindrical devices presents significant challenges. The anatomical structure of a child's heart (such as the left ventricular end-diastolic diameter) is only about 25-35 mm in children aged 1-3 years, and the size of existing devices and delivery systems (typically requiring a 23-27 Fr outer diameter sheath) are still too large for low-weight children. Furthermore, existing rigid leadless pacemakers are difficult to adapt to the curved structures of myocardial tissue or vascular walls, and post-implantation fit needs improvement.
[0005] Secondly, there are limitations to the fixation methods. Currently, there are two main methods for fixing leadless pacemakers during implantation: active spiral fixation and hook-and-loop fixation. Specifically, Micra uses nickel-titanium alloy spring plates to passively hook onto the trabeculae of the myocardium, while Aveir uses spiral screws to actively screw into the myocardium. These single-point or small-area fixation methods may cause long-term pressure and damage to the myocardial tissue, and there is a risk of dislocation under continuous cardiac pulsation. During active spiral fixation, to prevent the heart from being excessively screwed into the distal spiral of the leadless pacemaker, leading to the risk of perforation, a torque limiting structure is usually added to the leadless pacemaker or delivery device. In addition, if the fixation is not secure, the pulse generator needs to be retrieved and the implantation operation repeated. Multiple retrievals and repeated implantations not only increase the operation time but also cause repeated damage to the myocardium, increasing the risk of myocardial perforation. At the same time, during pullback, the retrieval cone and the device are prone to being out of sync, making it difficult for the device to return smoothly to the device cap.
[0006] Thirdly, the battery's shape and removal are challenging. As the core component of the pacemaker, the rigid cylindrical shape of the battery is the fundamental factor determining the overall device shape and rigidity. Developing novel battery technologies with excellent flexibility and safety is crucial for achieving smaller, more physiologically sound implantable devices. Furthermore, due to the limited lifespan of leadless pacemakers and the current inability to remove them 100%, patients may have multiple leadless pacemakers simultaneously. According to relevant literature, the success rate of chronic removal of leadless pacemakers is approximately 91%.
[0007] Flexible battery technology offers new possibilities for solving the aforementioned problems. Flexible batteries, especially thin-film batteries, can be bent and folded to adapt to complex implantation environments. Existing research has proposed the concept of using flexible batteries in implantable devices, such as constructing energy storage devices that can adapt to the anatomy of the circulatory system using flexible substrates and polymer electrolytes. However, applying flexible batteries to implantable medical devices, especially pacemakers that require a lifespan of 8-12 years, must meet extremely demanding requirements: extremely high energy density, excellent mechanical flexibility and durability, absolute biocompatibility, and long-term stability.
[0008] Among numerous electrochemical systems, lithium-ion fluorocarbon (Li / CFx) batteries have become an ideal choice for long-life implantable medical devices due to their extremely high theoretical energy density (approximately 2570 Wh / kg), flat discharge plateau, extremely low self-discharge rate, and excellent storage life. Lithium-ion fluorocarbon batteries are widely used in implantable medical devices such as pacemakers and neurostimulators. However, traditional Li / CFx battery electrodes are typically prepared using a slurry coating process, with point-like contact between the binder (such as PVDF) and the active material particles. During repeated bending and folding, the electrodes are prone to active material shedding, pulverization, and even breakage, leading to rapid capacity decay and battery failure. Furthermore, the inherently poor conductivity of fluorocarbon materials and the slow electrode kinetics result in voltage hysteresis and poor high-rate discharge capability in lithium / CFx batteries during discharge. These problems pose a significant challenge to the structural integrity of flexible pouch batteries.
[0009] Therefore, how to provide a flexible implantable battery for medical use and its preparation method, as well as a leadless cardiac pacemaker, should not only possess the advantages of high energy density and long lifespan of the Li / CFx system, but also have excellent flexibility and structural stability. Furthermore, it should be able to solve the limitations of existing leadless pacemakers in terms of size, shape, and fixation method through innovative structural design, especially the application challenges in pediatric patients. These are problems that urgently need to be solved by those skilled in the art. Summary of the Invention
[0010] In view of this, the present invention provides a medical implantable flexible battery and its preparation method, as well as a leadless pacemaker, aiming to solve the problems of rigid power supply (battery) of existing leadless pacemakers, such as large size, fixed shape, and difficulty in being suitable for special patient groups such as children. Specifically, the present invention aims to solve the following technical problems: First, how to prepare a lithium fluoride carbon battery cathode sheet that combines high energy density and excellent mechanical flexibility, so that it can maintain structural integrity and stable electrochemical performance when repeatedly bent and folded.
[0011] Second, how to construct an ultra-thin, flexible, and biocompatible flexible battery structure to meet the stringent requirements of implantable medical devices.
[0012] Third, how to design a novel battery form and deployment method that can be implanted in a minimally invasive manner and form a stable, low-damage fixation structure after implantation, which is particularly suitable for children's ventricles with limited space.
[0013] To achieve the above objectives, the present invention adopts the following technical solution: a medical implantable flexible battery, comprising: A positive electrode sheet, wherein the positive electrode sheet is a self-supporting flexible film, comprising a positive electrode active material, a conductive agent, and a polytetrafluoroethylene binder that has been sheared and fiberized; the positive electrode active material is fluorinated carbon, and the polytetrafluoroethylene binder forms a three-dimensional network skeleton, wherein the positive electrode active material and conductive agent particles are fixed in the three-dimensional network skeleton. A negative electrode sheet, wherein the negative electrode sheet is a lithium metal foil or a lithium alloy foil; An electrolyte layer, which is a solid polymer electrolyte layer or a quasi-solid polymer electrolyte layer, is disposed between the positive electrode and the negative electrode to conduct lithium ions and isolate the positive and negative electrodes; and A flexible encapsulation layer covers the positive electrode, the negative electrode, and the electrolyte layer.
[0014] The beneficial technical effects of this invention are as follows: By using a sheared and fiberized PTFE binder to construct a three-dimensional network skeleton, the positive electrode active material and conductive agent particles are firmly fixed in a self-supporting flexible film, enabling the positive electrode sheet to possess both excellent mechanical flexibility and structural stability without metal current collectors. This solves the technical problem of active material shedding and pulverization during repeated bending of traditional coated electrodes. At the same time, the high specific energy system of Li / CFx is used to achieve high compaction density. Combined with a solid / quasi-solid polymer electrolyte and a biocompatible flexible encapsulation layer, an integrated flexible battery with high energy density, ultra-thin design, and absolute safety is constructed.
[0015] Preferably, the conductive agent is one or more of acetylene black, Ketjen black, carbon nanotubes, and vapor-grown carbon fibers.
[0016] The resulting technical benefits are as follows: By selecting fluorinated carbon (CFx) as the positive electrode active material, its extremely high theoretical energy density (approximately 2570 Wh / kg), flat discharge plateau, and extremely low self-discharge rate provide the battery with a stable energy output of up to 8-12 years, meeting the stringent requirements for long lifespan in implantable medical devices; at the same time, the use of one or more of acetylene black, Ketjen black, carbon nanotubes, and vapor-grown carbon fibers as conductive agents effectively compensates for the inherent poor conductivity of fluorinated carbon materials, significantly improves the electronic conduction efficiency and rate performance of the electrode, and ensures high energy density and good conductivity.
[0017] This invention also discloses a medical implantable flexible battery, comprising: The positive electrode sheet is a high-density three-dimensional fluorinated carbon fiber positive electrode sheet, which is formed by rolling loose three-dimensional fluorinated carbon fiber. A negative electrode sheet, wherein the negative electrode sheet is a lithium metal foil or a lithium alloy foil; An electrolyte layer, which is a solid polymer electrolyte layer or a quasi-solid polymer electrolyte layer, is disposed between the positive electrode and the negative electrode to conduct lithium ions and isolate the positive and negative electrodes; and A flexible encapsulation layer covers the positive electrode, the negative electrode, and the electrolyte layer.
[0018] The resulting technical effect is that by eliminating conductive agents and binders, and constructing positive electrode sheets with pure fluorinated carbon fibers, the proportion of active materials is further increased and the preparation process is simplified while maintaining excellent flexibility and structural stability.
[0019] This invention also discloses a method for preparing a flexible implantable battery for medical use, wherein the preparation of the positive electrode includes the following steps: Step a: Fluorocarbon powder, conductive agent powder and polytetrafluoroethylene powder are dry-mixed under solvent-free conditions to obtain a mixed powder; Step b: Apply mechanical shear force to the mixed powder to cause the polytetrafluoroethylene particles to become fibrous, forming a three-dimensional network skeleton, and obtain a sheared fibrous mixture; Step c: Roll forming the sheared fiber mixture to obtain a self-supporting flexible thin-film positive electrode.
[0020] The resulting technical advantages are: the use of a solvent-free dry mixing process completely avoids the use and residual risks of organic solvents, significantly improving the biosafety of implantable batteries; the in-situ fiberization of PTFE particles induced by mechanical shear force constructs a three-dimensional network skeleton, allowing the active material and conductive agent particles to be tightly wrapped and fixed by the fibers in a "line contact" and "surface contact" manner, fundamentally overcoming the defects of traditional wet-coated electrodes where the binder only connects the particles in a point-like contact manner and is prone to falling off and pulverizing during repeated bending; and the self-supporting positive electrode film without metal current collector is directly obtained through roll forming, achieving a high compaction density of 1.5-2.0 g / cm³ to ensure high energy density while giving the electrode excellent flexibility (minimum bending radius ≤2mm). Moreover, the three-step process is seamless and efficient, without intermediate transfer, effectively improving product consistency and production efficiency.
[0021] Preferably, in step b, the mechanical shearing force is applied by using a twin-screw extruder, with the extruder chamber temperature at 60℃~80℃ and the screw speed at 100rpm~300rpm.
[0022] The resulting technical effect is as follows: using a twin-screw extruder as the shearing device, leveraging its advantages of strong shearing, continuous operation, and precise temperature control, the mixed powder is continuously sheared under conditions of a cavity temperature of 60℃~80℃ and a screw speed of 100rpm~300rpm. This temperature window ensures that the PTFE particles are in a suitable deformation state under shearing force to promote fiberization, while avoiding excessive softening or decomposition of PTFE due to excessively high temperatures. Too low a speed is insufficient for sufficient fiberization of PTFE, while too high a speed may cause excessive shearing and damage to the already formed fiber network structure. Thus, an efficient and controllable transformation of PTFE from granular to fibrous form is achieved.
[0023] This invention discloses a leadless cardiac pacemaker, comprising: Central base column; The pacing electrode is disposed on the central base pillar; and Multiple flexible battery long arms, each of the flexible battery long arms being a medical implantable flexible battery as described in any one of claims 1 to 3, or each of the flexible battery long arms being a flexible battery in the prior art; At least one end of each of the multiple flexible battery long arms is connected to the central base column and is electrically connected in parallel with each other; the leadless pacemaker has a contracted state and an extended state: in the contracted state, the multiple flexible battery long arms are gathered around the central base column and are contained within the delivery conduit; in the extended state, the multiple flexible battery long arms extend outward from the central base column to form a three-dimensional support structure.
[0024] The beneficial technical effects of this invention are as follows: By connecting at least one end of multiple flexible battery arms to the central base column and electrically connecting them in parallel, redundant storage of battery capacity is achieved. Furthermore, the bendable nature of the flexible battery arms allows the pacemaker to operate in two states: contracted and extended. In the contracted state, it can be housed within a small-diameter delivery catheter and delivered to the target cardiac chamber via minimally invasive vascular intervention, resulting in less damage to blood vessels, making it particularly suitable for pediatric patients with thinner blood vessels. In the extended state, its own elastic recovery force automatically conforms to the anatomical shape of the cardiac chamber. Compared to the rigid capsule-shaped units in existing technologies, this achieves multi-point, distributed, low-stress flexible contact and fixation, avoiding excessive local pressure and damage to myocardial tissue caused by single-point fixation, while also reducing the risk of dislocation during continuous cardiac pulsation.
[0025] Preferably, each of the flexible battery long arms is connected to the central base column at only one end, and the other end is a free end; in the unfolded state, each of the flexible battery long arms unfolds radially outward from the central base column to form an inverted umbrella-shaped three-dimensional structure.
[0026] The resulting technical effect is that, in the deployed state, each battery arm radiates outward from the central base to form an inverted umbrella-shaped three-dimensional structure. Its free end can naturally point towards the ventricular wall without additional auxiliary mechanisms, and the end can directly fit between the myocardial trabeculae. It can achieve adaptive multi-point anchoring by utilizing the inherent anatomical structure of the ventricle. Since the flexible battery arm itself has the dual functions of energy storage and structural support, it can maintain the deployed shape without additional rigid support skeleton, which simplifies the overall structure of the pacemaker and reduces the number of parts, which is conducive to further miniaturization.
[0027] Preferably, in the unfolded state, the free ends of each of the flexible battery long arms are used to abut or anchor between the myocardial trabeculae of the ventricular wall to achieve multi-point distributed fixation.
[0028] The resulting technical effect is that multi-point distributed anchoring without additional fixation mechanisms is achieved by utilizing the inherent anatomical structure of the ventricle. This disperses the fixation force across multiple contact points rather than concentrating it in a single location, significantly reducing local pressure on myocardial tissue and the risk of chronic damage. Even slight slippage at any contact point does not lead to overall fixation failure, thus ensuring long-term implantation stability and tissue compatibility.
[0029] Preferably, both ends of each of the flexible battery long arms are connected to the central base column, and the middle part bulges outward; in the unfolded state, each of the flexible battery long arms together forms a spherical cage-like or egg-shaped three-dimensional structure.
[0030] The resulting technical effect is that by connecting the two ends of each flexible battery arm to the central base column and making the middle bulge outward, the unfolded battery arms together form a spherical cage or egg-shaped three-dimensional structure. Compared with the single-end fixed inverted umbrella cantilever configuration, the arched structure constrained at both ends has higher structural rigidity and deformation resistance, and can maintain a more stable spatial configuration during heartbeat. At the same time, the spherical cage or egg-shaped structure achieves multi-point, multi-directional, large-area contact fixation with the ventricular wall in a way that better fits the geometry of the ventricular cavity, thus ensuring implantation stability, tissue compatibility, and anti-dislocation performance.
[0031] Preferably, each of the flexible battery long arms has a preset bending shape, and after the radial constraint of the delivery conduit is released, each of the flexible battery long arms automatically unfolds in all directions due to its own elastic restoring force.
[0032] The resulting technical effect is that each flexible battery arm has a preset bending shape, which allows it to automatically expand in all directions based on its own elastic recovery force after the radial constraint of the delivery catheter is released. It can complete the configuration transformation from the contracted state to the expanded state without the need for additional mechanical expansion mechanism or external power, thus simplifying the pacemaker implantation process, miniaturizing the structure, and making the expansion action gentle and controllable. It is especially suitable for pediatric patients with thinner blood vessels and limited cardiac chamber space. Attached Figure Description
[0033] Figure 1 This is a schematic diagram of a single-layer structure of a medical implantable flexible battery according to the present invention; Figure 2 This is a schematic diagram of the stacked structure of a medical implantable flexible battery according to the present invention; Figure 3 This is a schematic diagram of Embodiment 1 of a leadless cardiac pacemaker according to the present invention; Figure 4 This is a schematic diagram of embodiment 2 of the leadless cardiac pacemaker of the present invention; Figure 5 This is a schematic diagram of a leadless cardiac pacemaker of the present invention in the delivery state; Figure 6 This is a process flow diagram of the preparation process of a positive electrode sheet for a medical implantable flexible battery according to the present invention; Figure 7 This is a schematic diagram of the installation of a leadless pacemaker in the heart according to the present invention.
[0034] 1 Flexible battery, 11 Positive electrode, 12 Negative electrode, 13 Electrolyte layer, 14 Flexible encapsulation layer, 2 Central pillar, 3 Pacing electrode, 4 Flexible battery long arm, 5 Pacemaker electrode integrated chip, 6 Delivery conduit. Detailed Implementation
[0035] The technical solutions of the embodiments of the present invention will be clearly and completely described below with reference to the accompanying drawings. Obviously, the described embodiments are only some embodiments of the present invention, and not all embodiments. Based on the embodiments of the present invention, all other embodiments obtained by those skilled in the art without creative effort are within the scope of protection of the present invention.
[0036] See the appendix of this invention. Figure 1-2 According to an embodiment of the present invention, a medical implantable flexible battery comprises: The positive electrode 11 is a self-supporting flexible film containing a positive electrode active material, a conductive agent, and a polytetrafluoroethylene binder that has been sheared and fiberized. The polytetrafluoroethylene binder forms a three-dimensional network skeleton, in which the positive electrode active material and conductive agent particles are fixed. The thickness of a single layer is preferably 200-500 μm, and the thickness of a single layer in the stacked structure is preferably 100-250 μm. The negative electrode 12 is a lithium metal foil or a lithium alloy foil, and its thickness is preferably 30-60 μm. Electrolyte layer 13, which is a solid polymer electrolyte layer or a quasi-solid polymer electrolyte layer, is disposed between the positive electrode 11 and the negative electrode 12 to conduct lithium ions and isolate the positive and negative electrodes. The thickness of this layer is preferably 30-40 μm, and the thickness of a single layer in the stacked structure is preferably 15-20 μm. The flexible encapsulation layer 14 covers the positive electrode 11, the negative electrode 12 and the electrolyte layer 13, with a preferred thickness of 20-50 μm. It is encapsulated in multiple layers using a flexible polymer material with excellent biocompatibility, such as parylene-C or polyimide (PI), to ensure the biocompatibility of the battery with human tissue and its long-term electrochemical stability.
[0037] Through a hot-pressing lamination process, the above layers are tightly bonded together to form a single flexible battery cell. The total thickness of the entire battery cell is controlled between 0.4-0.7mm, ensuring its ultra-thin and flexible characteristics. In particular, the thinner thickness of the positive electrode sheet in the stacked structure further enhances its flexibility.
[0038] In other embodiments, the positive electrode active material is fluorinated carbon, and the conductive agent is one or more of acetylene black, Ketjen black, carbon nanotubes, and vapor-grown carbon fibers. High-specific-capacity fluorinated carbon ((CF)n, n≈0.9-1.1) powder with a particle size D50 of 1-5 μm can be selected.
[0039] The binder is a polytetrafluoroethylene (PTFE) emulsion dispersion powder with an average particle size of less than 10 μm.
[0040] The core of the positive electrode in this embodiment lies in the fact that the PTFE binder undergoes fibrosis under specific mechanical shear force, forming a three-dimensional network framework. This fibrous network tightly crosslinks, entangles, and fixes the fluorinated carbon active material particles and conductive agent particles together, thereby endowing the entire positive electrode with excellent mechanical toughness and bending resistance, and maintaining structural self-support even in the absence of a metal current collector.
[0041] The preparation of the positive electrode 11 includes the following steps: Step a: Fluorocarbon powder, conductive agent powder, and polytetrafluoroethylene powder are uniformly mixed in a predetermined ratio under solvent-free conditions to obtain a mixed powder. Specifically, by mass percentage, 90% of the fluorocarbon powder, 5% of the composite conductive agent, and 5% of the PTFE powder are placed in a high-speed mixer. Dry mixing is performed for 15 minutes without adding any solvent to allow for initial uniform dispersion of the components. Step b: Apply mechanical shear force to the mixed powder. Under the action of this shear force, the PTFE particles are stretched and deformed to form nanoscale microfibers, i.e., "fibrillation" occurs. This causes the polytetrafluoroethylene particles to fibrose and form a three-dimensional network skeleton, resulting in a shear-fibrillated mixture. Step c involves rolling the sheared fibrous mixture to obtain a self-supporting flexible thin-film positive electrode. Specifically, the material extruded from the extruder, which is in the form of a plastic dough, is immediately fed into a pair of precision rollers for rolling.
[0042] Set the roller pressing pressure to 50-125 MPa, the roller pressing linear speed to 0.5-2 m / min, and maintain the roller surface temperature at 80-120°C.
[0043] Under high temperature and pressure, the PTFE fiber network is further densified and thermally bonded, compacting all components into a self-supporting positive electrode film with uniform thickness, smooth surface, and excellent flexibility and tensile strength. The resulting positive electrode sheet 104 has a compaction density of 1.5-2.0 g / cm³. When bent to a radius of 2 mm, no cracks appear on its surface, and the conductivity does not decrease significantly.
[0044] In step b, the mechanical shearing force is applied by using a twin-screw extruder for shearing, with the extruder chamber temperature at 60℃~80℃ and the screw speed at 100rpm~300rpm.
[0045] In other embodiments, a medical implantable flexible battery includes: Positive electrode 11 is a high-density three-dimensional fluorinated carbon fiber positive electrode, which is formed by rolling loose three-dimensional fluorinated carbon fiber. Negative electrode 12, which is a lithium metal foil or a lithium alloy foil; Electrolyte layer 13, which is a solid polymer electrolyte layer or a quasi-solid polymer electrolyte layer, is disposed between the positive electrode 11 and the negative electrode 12 to conduct lithium ions and isolate the positive and negative electrodes; and A flexible encapsulation layer 14 covers the positive electrode 11, the negative electrode 12, and the electrolyte layer 13.
[0046] The core of the positive electrode in this embodiment lies in its high-density, three-dimensional fluorinated carbon fiber positive electrode sheet. It is formed by rolling loose three-dimensional fluorinated carbon fibers.
[0047] In this embodiment, the three-dimensional fluorinated carbon fiber is directly placed into a precision roller press for rolling. The rolling pressure is set to 50-125 MPa, the rolling linear speed is 0.5-2 m / min, and the roller surface temperature is maintained at 80-120°C. Under high temperature and high pressure, the loose three-dimensional fluorinated carbon fiber is pressed into a high-density self-supporting positive electrode film, resulting in a positive electrode sheet with a compaction density of 1.5-2.0 g / cm³.
[0048] Reference Appendix Figure 6 For the battery manufacturing process.
[0049] Compared with existing technologies, the aforementioned flexible batteries exhibit superior flexibility and mechanical durability: The flexible battery of this invention has a minimum bending radius of 2mm and can withstand heartbeats while maintaining structural and performance stability.
[0050] High energy density and long lifespan: Utilizing a high specific energy Li / CFx chemical system combined with a high-density cathode, the battery ensures stable power supply for leadless pacemakers for 8-12 years in a very small size and weight, meeting the needs of long-term implantation.
[0051] Extreme thinness and miniaturization: The overall package thickness can be controlled within 0.4-0.7mm. The long battery cells can be folded and retracted during delivery, greatly reducing the diameter of the delivery system and making it more suitable for pediatric patients with smaller blood vessels.
[0052] It also features an innovative biomimetic fixation structure: an "inverted umbrella" or "cage"-like deployment and fixation method that utilizes the natural anatomical structure inside the ventricle (trabeculae of the myocardium) to achieve multi-point, distributed, and flexible fixation. This method results in uniform stress distribution, minimal trauma and stimulation to the myocardial tissue, and a more robust fixation effect that better meets biomechanical requirements.
[0053] Enhanced safety: The use of solid or quasi-solid electrolytes completely eliminates the risk of electrolyte leakage, which is crucial for medical devices implanted in the human body.
[0054] Modularity and scalability: By connecting different numbers of battery chips in parallel, the total capacity and output power of the battery pack can be easily adjusted to adapt to medical devices with different power consumption requirements, demonstrating good platformization and scalability.
[0055] The present invention also discloses a leadless cardiac pacemaker, comprising: The central pillar 2, made of polyimide or perene, is internally sealed and encapsulates the positive and negative electrode lines of each thin-film battery. The end of the pillar has connections to the pacing and sensing electrodes. Pacemaker electrode integrated chip 5: It has the same appearance and structure as the flexible battery arm, is fixed on the central base column, and there are 1-2 chips. Together with the flexible battery arm, they form a fixing device. The pacing electrode 3 is disposed on the central base post 2; and Multiple flexible battery long arms 4 (e.g., 3-8), each flexible battery long arm 4 being the aforementioned medical implantable flexible battery or a flexible battery in the prior art; At least one end of each of the multiple flexible battery long arms 4 is connected to the central base column 2 and is electrically connected in parallel. The parallel design not only increases the total battery capacity but also provides redundancy, so that the system can continue to work even if individual battery arms fail. The leadless pacemaker has a contracted state and an extended state: in the contracted state, the multiple flexible battery long arms 4 are gathered around the central base column 2 and are contained within the delivery conduit 6; in the extended state, the multiple flexible battery long arms 4 extend outward from the central base column 2 to form a three-dimensional support structure.
[0056] Example 1, see attached document Figure 3 Each flexible battery elongated arm 4 is connected to the central base post 2 at only one end, with the other end being free. In the unfolded state, each flexible battery elongated arm 4 radiates outward from the central base post 2, forming an inverted umbrella-shaped three-dimensional structure. The dimensions of each elongated arm are approximately: length 20-35mm, width 6-10mm, and thickness 0.4-0.7mm. These 3-6 thin-film batteries are directly integrated with the central base post and located around the central base post.
[0057] In Example 1, in the unfolded state, the free ends of each flexible battery long arm 4 are used to abut or anchor between the myocardial trabeculae of the ventricular wall to achieve multi-point distributed fixation.
[0058] Example 2, see attached document Figure 4 Each flexible battery long arm 4 has its two ends connected to the central base column 2, with the middle part bulging outwards; in the unfolded state, each flexible battery long arm 4 together forms a spherical cage or egg-shaped three-dimensional structure.
[0059] Reference Appendix Figure 7 Each flexible battery long arm 4 has a preset bending shape. After the radial constraint of the delivery conduit 6 is released, each flexible battery long arm 4 automatically unfolds in all directions due to its own elastic restoring force.
[0060] Reference Appendix Figure 5 During implantation, these parallel battery segments are contracted, bent, or folded, and housed together with the central pillar in a narrow delivery catheter. The overall structure is compact and can be delivered to the target cardiac chamber (such as the right ventricle) via minimally invasive vascular intervention.
[0061] Deployment state: After reaching the predetermined position in the ventricle, the device is released from the delivery catheter. Due to the elasticity of the material and the preset shape, or through simple mechanical assistance, the individual battery segments will automatically deploy to form a three-dimensional structure resembling an "inverted umbrella" or a "cage".
[0062] Fixation method: The "inverted umbrella" or "ball cage" support arms are the flexible battery panels. Once unfolded, the ends or sides of these panels gently abut or anchor between the trabeculae of the ventricular wall. This multi-point, large-area, distributed, and flexible contact method, compared to the single-point rigid fixation of existing technologies, exerts less pressure on the myocardial tissue, provides more stable fixation, better adapts to heartbeats, and exhibits better long-term biocompatibility.
[0063] The apparatus and methods disclosed in the embodiments are described simply because they correspond to the methods disclosed in the embodiments. For relevant details, please refer to the method section.
[0064] The above description of the disclosed embodiments enables those skilled in the art to make or use the invention. Various modifications to these embodiments will be readily apparent to those skilled in the art, and the general principles defined herein may be implemented in other embodiments without departing from the spirit or scope of the invention. Therefore, the invention is not to be limited to the embodiments shown herein, but is to be accorded the widest scope consistent with the principles and novel features disclosed herein.
Claims
1. A medical implantable flexible battery, characterized in that, include: A positive electrode (11) is a self-supporting flexible film containing a positive electrode active material, a conductive agent and a polytetrafluoroethylene binder that has been sheared and fiberized; the positive electrode active material is fluorinated carbon, and the polytetrafluoroethylene binder forms a three-dimensional network skeleton, and the positive electrode active material and conductive agent particles are fixed in the three-dimensional network skeleton. The negative electrode (12) is a lithium metal foil or a lithium alloy foil; An electrolyte layer (13), which is a solid polymer electrolyte layer or a quasi-solid polymer electrolyte layer, is disposed between the positive electrode (11) and the negative electrode (12) for conducting lithium ions and isolating the positive and negative electrodes; and A flexible encapsulation layer (14) covers the positive electrode (11), the negative electrode (12), and the electrolyte layer (13).
2. The medical implantable flexible battery according to claim 1, characterized in that, The conductive agent is one or more of acetylene black, Ketjen black, carbon nanotubes, and vapor-grown carbon fibers.
3. A medical implantable flexible battery, characterized in that, include: Positive electrode (11), wherein the positive electrode (11) is a high-density three-dimensional fluorinated carbon fiber positive electrode, which is formed by rolling loose three-dimensional fluorinated carbon fiber; The negative electrode (12) is a lithium metal foil or a lithium alloy foil; An electrolyte layer (13), which is a solid polymer electrolyte layer or a quasi-solid polymer electrolyte layer, is disposed between the positive electrode (11) and the negative electrode (12) for conducting lithium ions and isolating the positive and negative electrodes; and A flexible encapsulation layer (14) covers the positive electrode (11), the negative electrode (12), and the electrolyte layer (13).
4. A method for preparing a medical implantable flexible battery as described in claim 1 or 2, characterized in that, The preparation of the positive electrode (11) includes the following steps: Step a: Fluorocarbon powder, conductive agent powder and polytetrafluoroethylene powder are dry-mixed under solvent-free conditions to obtain a mixed powder; Step b: Apply mechanical shear force to the mixed powder to cause the polytetrafluoroethylene particles to become fibrous, forming a three-dimensional network skeleton, and obtain a sheared fibrous mixture; Step c: Roll forming the sheared fiber mixture to obtain a self-supporting flexible thin-film positive electrode.
5. The method for preparing a medical implantable flexible battery according to claim 4, characterized in that, In step b, the mechanical shearing force is applied by using a twin-screw extruder for shearing, with the extruder chamber temperature at 60℃~80℃ and the screw speed at 100rpm~300rpm.
6. A leadless cardiac pacemaker, characterized in that, include: Central base column (2); The pacing electrode (3) is disposed on the central base column (2); as well as Multiple flexible battery long arms (4), each of the flexible battery long arms (4) being a medical implantable flexible battery; At least one end of each of the multiple flexible battery long arms (4) is connected to the central base column (2) and is electrically connected in parallel with each other; the leadless pacemaker has a contracted state and an extended state: in the contracted state, the multiple flexible battery long arms (4) are gathered around the central base column (2) and are contained in the delivery conduit (6); in the extended state, the multiple flexible battery long arms (4) extend outward from the central base column (2) to form a three-dimensional support structure.
7. A leadless cardiac pacemaker according to claim 6, characterized in that, Each of the flexible battery long arms (4) is connected to the central base column (2) at only one end, and the other end is a free end; in the unfolded state, each of the flexible battery long arms (4) unfolds radially outward from the central base column (2) to form an inverted umbrella-shaped three-dimensional structure.
8. A leadless cardiac pacemaker according to claim 7, characterized in that, In the unfolded state, the free ends of each of the flexible battery long arms (4) are used to abut or anchor between the myocardial trabeculae of the ventricular wall to achieve multi-point distributed fixation.
9. A leadless cardiac pacemaker according to claim 6, characterized in that, Each of the flexible battery long arms (4) is connected to the central base column (2) at both ends, and the middle part bulges outward; in the unfolded state, each of the flexible battery long arms (4) together forms a spherical cage or egg-shaped three-dimensional structure.
10. A leadless cardiac pacemaker according to claim 6, characterized in that, Each of the flexible battery long arms (4) has a preset bending shape. After the radial constraint of the delivery conduit (6) is released, each of the flexible battery long arms (4) automatically unfolds in all directions due to its own elastic restoring force.
